Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial
Clinical trial NCT01272557 · UNKNOWN
Trial details
- NCT number
- NCT01272557
- Sponsor
- PD Dr. med. Matthias Dollinger
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2014-09-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.